Emcure Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Emcure Pharma

DeciZen not available for IPO

10 Year X-Ray of Emcure Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 17.2%25.7%22.6%17.1%13.1%13.5%8.5%14%14.4%7.7%-
Value Creation
Index
0.20.80.60.2-0.10.0-0.400.0-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1,6292,0312,1372,0582,2412,4542,3763,1543,3873,1073,154
Sales YoY Gr.-24.7%5.2%-3.7%8.9%9.5%-3.2%32.8%7.4%-8.3%-
Adj EPS 9.517.919.416.513.915.7922.423.1823.3
YoY Gr.-88.1%8.2%-14.8%-15.9%12.8%-42.7%150.2%2.9%-65.5%-
BVPS (₹) 40.547.560.167.177.197.4104.4126.693.8101126.6
Adj Net
Profit
172324350298251283162406418144420
Cash Flow from Ops. 288280251325401371385775428505-
Debt/CF from Ops. 2.42.43.83.22.83.33.12.13.73.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.4%6.8%9.4%-8.3%
Adj EPS -2%-10.5%-3.9%-65.5%
BVPS10.7%5.5%-1.1%7.6%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
25.840.73625.81917.88.819.320.88.120.4
Op. Profit
Mgn %
2025.127.824.423.623.31823.623.514.1NAN
Net Profit
Mgn %
10.61616.414.511.211.56.812.912.34.613.3
Debt to
Equity
0.90.80.90.90.80.70.60.70.90.9-
Working Cap
Days
1921782152302012292822432392500
Cash Conv.
Cycle
49497710489111155108971140

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Emcure Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 23.3 0
TTM Sales (₹ Cr.) 3,154 0
BVPS (₹.) 126.6 10
Reserves (₹ Cr.) 2,109 -
P/BV 0.00 0.00
PE 0.00 0.00
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 180.9
Face Value (₹) 10
Industry PE 48.8

Management X-Ray of Emcure Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Emcure Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales1,628.642,031.012,137.012,058.412,241.432,453.702,375.713,153.663,387.243,107.09
Operating Expenses 1,302.401,520.521,545.511,574.511,713.831,883.301,952.292,410.262,592.572,668.59
Manufacturing Costs58.12270.71265.81207.36238.68237.65191.78213.40384.02378.03
Material Costs627.92635.78540.14532.73608.65744.80811.161,246.401,162.901,087.41
Employee Cost 286.79342.91418.99439.59484.13516.14545.35550.96603.95649.18
Other Costs 329.57271.12320.56394.83382.37384.71404399.51441.70553.98
Operating Profit 326.24510.48591.50483.90527.60570.41423.42743.41794.67438.49
Operating Profit Margin (%) 20.0%25.1%27.7%23.5%23.5%23.2%17.8%23.6%23.5%14.1%
Other Income 19.7764.6140.4255.056190.88137.62111.91132.68125.35
Interest 75.8677.6075.73100.8888.05126.65137.22123.34145.14166.83
Depreciation 61.58103.81104.43115.84119.97129.84154.97156.24165.79178.52
Exceptional Items -7.22-174.35-54.39-98.37-38.14-34.96-44.16-18.290-6.15
Profit Before Tax 201.35219.33397.37223.86342.45369.84224.68557.45616.42212.34
Tax 26.9212.6679.416.7099.6886.1849.48136.97169.6152.28
Profit After Tax 174.43206.67317.96217.16242.77283.65175.21420.48446.81160.06
PAT Margin (%) 10.7%10.2%14.9%10.5%10.8%11.6%7.4%13.3%13.2%5.2%
Adjusted EPS (₹)9.611.417.612.013.415.79.723.324.78.9
Dividend Payout Ratio (%)26%33%57%25%26%22%26%4%12%23%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 732.24858.721,087.551,213.011,394.271,762.211,887.642,290.051,696.611,825.87
Share Capital 45.2145.21180.85180.85180.85180.85180.85180.85180.85180.85
Reserves 687.03813.51906.691,032.161,213.411,581.351,706.792,109.201,515.751,645.02
Minority Interest0000000000
Debt563.16542.18773.51839.25917.97985.661,014.801,305.571,361.311,418.61
Long Term Debt326.30253.01409.11453.02407.58442.39453.87645.97512.40600.65
Short Term Debt236.86289.17364.39386.23510.39543.28560.93659.59848.91817.96
Trade Payables324.97297.48271.94221.98343.48323.52438.62574.29601.37673.44
Others Liabilities 521.15397.47684.50343.80412.75506.18530.14693.29663.90697.94
Total Liabilities 2,141.522,095.852,817.492,618.043,068.463,577.573,871.204,863.204,323.184,615.85

Fixed Assets

Gross Block1,017.651,104.131,369.301,099.921,226.791,563.011,772.122,024.102,187.182,472.14
Accumulated Depreciation287.89379.71479.37219.51334.96463.08606.06746.20879.821,039.44
Net Fixed Assets729.76724.42889.93880.40891.821,099.921,166.061,277.901,307.361,432.71
CWIP 179.6773.8571.34288.43469.09405.96326.06192.09239.25253.10
Investments 183.43228.15290.63298.10305.01310.57407.71863.73563.36690.02
Inventories334.82342.82512.93547.04476.44495.65443.66621.77730.44709.93
Trade Receivables344.60401.33461.67352.79532.17910.111,138.29999.431,009.091,054.50
Cash Equivalents 69.7732.2238.1227.3654.1428.5039.22260.7347.88141.02
Others Assets299.46293.06552.87223.92339.78326.85350.21647.55425.80334.58
Total Assets 2,141.522,095.852,817.492,618.043,068.463,577.573,871.204,863.204,323.184,615.85

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 287.87280.39250.67325.27401.09371.17385.25774.87427.71505.37
PBT 201.35219.33397.37223.86342.45369.84224.68557.45616.42212.34
Adjustment 137.93305.32159.09194.64201.76522.79261.78246.72265309.21
Changes in Working Capital -14.95-200.27-239.19-27.32-93.8-396-70.584.38-283.0468.37
Tax Paid -36.46-43.99-66.60-65.91-49.31-125.45-30.71-113.67-170.67-84.54
Cash Flow From Investing Activity -213.05-118.36-332.66-299.57-287.34-275.76-164.76-831.16-189-270.44
Capex -197.07-171.54-278.61-312.47-283.24-286.64-97.84-97.79-184.24-280.20
Net Investments 00000.290.778.19-5.9600
Others -15.9853.18-54.0512.90-4.3810.11-75.11-727.42-4.769.76
Cash Flow From Financing Activity -24.14-194.3483.56147.21-216.76-53.46-45.8730.97-342.96-54.52
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000079.72-42.15326.89-228.2591.68
Interest Paid -75.32-79.42-73.59-91.96-88.86-128.91-123.32-118.70-131.37-142.07
Dividend Paid -16.12-103.40-118.38-31.03-64.49-96.64-48.27-18.09-54.26-36.17
Others 67.30-11.52275.53270.20-63.4192.36167.88-159.1470.9232.05
Net Cash Flow 50.68-32.311.57172.92-10341.95174.62-25.32-104.25180.42
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)26.1825.9832.6718.8818.6217.979.620.1322.429.09
ROCE (%)21.1320.1826.4715.0718.0218.0111.8519.4221.1611.15
Asset Turnover Ratio0.860.980.890.770.790.740.640.720.740.7
PAT to CFO Conversion(x)1.651.360.791.51.651.312.21.840.963.16
Working Capital Days
Receivable Days7266727172107157124108121
Inventory Days62607292837272627385
Payable Days163179192169170163171148185214

Emcure Pharmaceuticals Ltd Stock News

Emcure Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Emcure Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Emcure Pharma stood at ₹0.00.
The latest P/E ratio of Emcure Pharma as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Emcure Pharma as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Emcure Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Emcure Pharma is ₹3,154 ( Cr.) .

About Emcure Pharmaceuticals Ltd

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.